A shadow market for unapproved slimming medications is propelled by social media fitness personalities and sellers on communication apps, according to recent findings.
Experimental Treatment Acquiring Traction Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Followers are encouraged to message these profiles privately for source information, while also receiving promotional offers.
Active Commerce on Messaging Platforms
Separately, a robust market exists on Telegram, where communities with thousands of members share “before and after” photos, injection guides and claims of rapid UK delivery. Sellers promote the substance there before redirecting customers to WhatsApp for transactions.
Understanding The Experimental Drug
Retatrutide is an experimental injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.
Healthcare Experts Express Concerns
Nevertheless, doctors and chemists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in users injecting substances of unknown origin.
Some professionals stated the popularity for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.
Regulatory Position and Implementation
Marketing the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Some influencers attempt to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, advertising, and customer regulations, risking penalties, prosecution or prison.
Platform Response and Material Removal
Based on TikTok, the service has removed problematic content and prohibited related keywords and query recommendations. The company said it was dedicated to keeping the platform secure and investing in enhancing compliance measures.
Online Marketplace Activities
Investigations also found communities with up to nine thousand members selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, filled with images of weight loss, glowing testimonials and step-by-step guides for mixing or injecting at residence.
Within minutes of joining one group, a vendor posted contact information, where most purchases occur. The seller provided an instruction manual and guaranteed delivery within two days. When asked whether the substance was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about weight, medical conditions or past usage.
Product Details and Costs
Within these groups, messages show dark colored packages with postal service labels, claiming to include new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how much time a injector should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A spokesperson for the messaging service stated it regularly monitored dangerous content on its platform including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are administering materials they can’t verify. Although the science behind retatrutide is valid, these digital versions may not include what they claim,” stated a pharmacy expert, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the increase in interest to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit treatments are extremely dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.
Her staff has previously encountered individuals injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but purchasing from Telegram or communication platforms is gambling with your health,” stated Wyllie. “These substances could be impure or incorrectly dosed.”
Producer Statement
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority globally. “Consequently at this point no one can market [it] for human use,” they explained, adding that any item “misleadingly claiming itself as a company experimental product not yet authorized … may subject patients to possibly significant health risks”.
